190 related articles for article (PubMed ID: 28025432)
1. Visfatin levels in gingival crevicular fluid and serum before and after non-surgical treatment for periodontal diseases.
Türer ÇC; Balli U; Güven B; Çetinkaya BÖ; Keleş GÇ
J Oral Sci; 2016; 58(4):491-499. PubMed ID: 28025432
[TBL] [Abstract][Full Text] [Related]
2. Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease.
Pradeep AR; Raghavendra NM; Prasad MV; Kathariya R; Patel SP; Sharma A
J Periodontol; 2011 Sep; 82(9):1314-9. PubMed ID: 21309715
[TBL] [Abstract][Full Text] [Related]
3. Effect of non surgical periodontal therapy on gingival crevicular fluid and serum visfatin concentration in periodontal health and disease.
Raghavendra NM; Pradeep AR; Kathariya R; Sharma A; Rao NS; Naik SB
Dis Markers; 2012; 32(6):383-8. PubMed ID: 22684235
[TBL] [Abstract][Full Text] [Related]
4. Effect of non-surgical periodontal treatment on visfatin concentrations in serum and gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus.
Wu Y; Chen L; Wei B; Luo K; Yan F
J Periodontol; 2015 Jun; 86(6):795-800. PubMed ID: 25786566
[TBL] [Abstract][Full Text] [Related]
5. The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease.
Çetiner D; Uraz A; Öztoprak S; Akça G
J Appl Oral Sci; 2019 Jul; 27():e20180365. PubMed ID: 31365708
[TBL] [Abstract][Full Text] [Related]
6. Expression of visfatin in gingival crevicular fluid and gingival tissues in different periodontal conditions: a cross-sectional study.
Xiao K; Chen L; Mao Y; Bao H; Chen W; Li X; Wu Y
BMC Oral Health; 2024 May; 24(1):514. PubMed ID: 38698364
[TBL] [Abstract][Full Text] [Related]
7. Assessment of periostin levels in serum and gingival crevicular fluid of patients with periodontal disease.
Balli U; Keles ZP; Avci B; Guler S; Cetinkaya BO; Keles GC
J Periodontal Res; 2015 Dec; 50(6):707-13. PubMed ID: 25529858
[TBL] [Abstract][Full Text] [Related]
8. Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus.
Pradeep AR; Raghavendra NM; Sharma A; Patel SP; Raju A; Kathariya R; Rao NS; Naik SB
J Periodontol; 2012 May; 83(5):629-34. PubMed ID: 21966944
[TBL] [Abstract][Full Text] [Related]
9. The comparison of visfatin levels of gingival crevicular fluid in systemic lupus erythematosus and chronic periodontitis patients with healthy subjects.
Rezaei M; Bayani M; Tasorian B; Mahdian S
Clin Rheumatol; 2019 Nov; 38(11):3139-3143. PubMed ID: 31372850
[TBL] [Abstract][Full Text] [Related]
10. Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levels.
Pradeep AR; Manjunath RG; Kathariya R
J Investig Clin Dent; 2010 Nov; 1(2):133-8. PubMed ID: 25427270
[TBL] [Abstract][Full Text] [Related]
11. Effect of non-surgical periodontal treatment on visfatin and chemerin concentration in the gingival crevicular fluid.
Bengi VU; Özcan E; Saygun NI; Guler OS; Serdar MA
Odontology; 2024 Jan; 112(1):200-207. PubMed ID: 36976366
[TBL] [Abstract][Full Text] [Related]
12. Plasma and crevicular fluid osteopontin levels in periodontal health and disease.
Sharma CG; Pradeep AR
J Periodontal Res; 2007 Oct; 42(5):450-5. PubMed ID: 17760823
[TBL] [Abstract][Full Text] [Related]
13. Gingival crevicular fluid can degrade Emdogain and inhibit Emdogain-induced proliferation of periodontal ligament fibroblasts.
Laaksonen M; Salo T; Vardar-Sengul S; Atilla G; Saygan BH; Simmer JP; Baylas H; Sorsa T
J Periodontal Res; 2010 Jun; 45(3):353-60. PubMed ID: 19909398
[TBL] [Abstract][Full Text] [Related]
14. Periodontopathogens and human β-defensin-2 expression in gingival crevicular fluid from patients with periodontal disease in Guangxi, China.
Yong X; Chen Y; Tao R; Zeng Q; Liu Z; Jiang L; Ye L; Lin X
J Periodontal Res; 2015 Jun; 50(3):403-10. PubMed ID: 25065393
[TBL] [Abstract][Full Text] [Related]
15. Effects of Systemic Simvastatin on the Concentrations of Visfatin, Tumor Necrosis Factor-
Bahammam MA; Attia MS
J Immunol Res; 2018; 2018():8481735. PubMed ID: 30186882
[TBL] [Abstract][Full Text] [Related]
16. Gingival crevicular fluid and plasma levels of neuropeptide Substance-P in periodontal health, disease and after nonsurgical therapy.
Pradeep AR; Raj S; Aruna G; Chowdhry S
J Periodontal Res; 2009 Apr; 44(2):232-7. PubMed ID: 18973530
[TBL] [Abstract][Full Text] [Related]
17. Effect of periodontal therapy on lactoferrin levels in gingival crevicular fluid.
Yadav N; Lamba AK; Thakur A; Faraz F; Tandon S; Pahwa P
Aust Dent J; 2014 Sep; 59(3):314-20. PubMed ID: 24913177
[TBL] [Abstract][Full Text] [Related]
18. Periodontal disease and visfatin level: A systematic review and meta-analysis.
Bayani M; Heidari M; Almasi-Hashiani A
PLoS One; 2023; 18(11):e0293368. PubMed ID: 37934738
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of gingival crevicular fluid cyclophilin a and extracellular matrix metalloproteinase inducer levels in different periodontal diseases.
Eren G; Türkoğlu O; Atmaca H; Atilla G
Arch Oral Biol; 2016 Aug; 68():162-6. PubMed ID: 27176139
[TBL] [Abstract][Full Text] [Related]
20. Levels of vaspin and omentin-1 in gingival crevicular fluid as potential markers of inflammation in patients with chronic periodontitis and type 2 diabetes mellitus.
Bozkurt Doğan Ş; Öngöz Dede F; Ballı U; Sertoğlu E
J Oral Sci; 2016; 58(3):379-89. PubMed ID: 27665978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
